• Title/Summary/Keyword: Hydroxyapatite ocular implant

Search Result 5, Processing Time 0.025 seconds

Evaluation of Fibrovascular Ingrowth into the Hydroxyapatite Ocular Implant by $^{99m}Tc$-MDP Bone Scintigraphy (골신티그라피에 의한 Hydroxyapatite 안구삽입물로의 섬유혈관증식 평가)

  • Bom, Hee-Seung;Song, Ho-Chun;Kim, Ji-Yeul;Jeong, Sang-Ki;Park, Young-Kul
    • The Korean Journal of Nuclear Medicine
    • /
    • v.27 no.2
    • /
    • pp.256-260
    • /
    • 1993
  • Thirteen patients received a coralline hydroxyapatite sphere as a buried integrated ocular implant after enucleation surgery. The implant was modified by multiple drillings, 1 mm in diameter, to the center of the sphere to allow more rapid host tissue ingrowth. $^{99m}Tc$-MDP planar and tomographic bone scintigraphies were performed at various intervals after implantation (from 100 to 742 days after operation) to assess vascularization of the implant. All patients showed hot uptakes in the implants. These patients underwent a secondary drilling for the final motility peg application. The confirmation of vascular ingrowth was done by inspection of bleeding at the time of bleeding at the time of drilling from the center of the implant. Bleeding from the drilled implant was noted in all patients. In cnclusion, hot uptake in the implanted ocular hydroxyapatite implant accurately reflect vascular ingrowth into the implant.

  • PDF

Assessment of Vascularization within Hydroxyapatite Ocular Implant by Bone Scintigraphy: Comparative Analysis of Planar and SPECT Imaging (Hydroxyapatite 안구보충물삽입술 후 골신티그라피를 이용한 섬유혈관증식 평가: 평면영상과 SPECT 영상에서의 비교)

  • Lim, Seok-Tae;Sohn, Myung-Hee;Park, Soon-Ah
    • The Korean Journal of Nuclear Medicine
    • /
    • v.33 no.6
    • /
    • pp.475-483
    • /
    • 1999
  • Purpose: Complete fibrovascular ingrowth within the hydroxyapatite ocular implant is necessary for peg drilling which is performed to Prevent infection and to provide motility to the ocular prosthesis. We compared planar bone scintigraphy and SPECT for the evaluation of the vascularization within hydroxyapatite ocular implants. Materials and Methods: Seventeen patients (M:F: 12:5, mean age; $50.4{\pm}17.5$ years) who had received a coralline hydroxyapatite ocular implant after enucleation surgery were enrolled. Patients underwent Tc-99m MDP planar bone and SPECT imaging by dual head gamma camera after their implant surgery (interval: $197{\pm}81$ days). Uptake on planar and SPECT images was graded visually as less than (grade 1), equal to (grade 2), and greater than (grade 3) nasal bridge activity. Quantitative ratio of implanted to non-implanted intraorbital activity was also measured. Vascularization within hydroxyapatite implants was confirmed by slit lamp examination and ocular movement. Results: All but three patients were considered to be vascularized within hydroxyapatite implants. In visual analysis of planar image and SPECT, grade 1 was noted in 9/18 (50%) and 6/18 (33%), respectively. Grade 2 pattern was 7/18 (39%) and 4/18 (22%), and grade 3 pattern was 2/18 (11%) and 8/18 (44%) respectively. When grade 2 or 3 was considered to be positive for vascularization, the sensitivity of planar and SPECT imaging were 60% (9/15) and 80% (12/15), respectively. In 3 patients with incomplete vascularization, both planar and SPECT showed grade 1 uptake The orbital activity ratios on planar imaging were not significantly different between complete and incomplete vascularization ($1.96{\pm}0.87$ vs $1.17{\pm}0.08$, p>0.05), however, it was significantly higher on SPECT in patients with complete vascularization ($8.44{\pm}5.45$ vs $2.20{\pm}0.87$, p<0.05). Conclusion: In the assessment of fibrovascular ingrowth within ocular implants by Tc-99m MDP bone scintigraphy, SPECT image appears to be more effective than planar scintigraphy.

  • PDF

Usefulness of $^{99m}Tc$-MDP Bone Scintigraphy for Assessing Vascular Ingrowth on Hydroxyapatite Ocular Implant ($^{99m}Tc$-MDP 골신티그라피를 이용한 Hydroxyapatite 안구 보충물의 혈관 신생 평가 및 임상적 유용성)

  • Kang, Bong-Joo;Sohn, Hyung-Sun
    • The Korean Journal of Nuclear Medicine
    • /
    • v.33 no.6
    • /
    • pp.484-492
    • /
    • 1999
  • Purpose: This study was to evaluate the clinical usefulness of $^{99m}Tc$-MDP bone scintigraphy for assessing vascular ingrowth into the ocular implants after enucleation or evisceration. Materials and Methods: Twenty-four patients (M:F=7:17, mean age: 36 years), who buried a coralline hydroxyapatite after uncomplicated enucleation or evisceration surgery were studied. Dynamic and static scintigraphy on the orbit fossa were obtained after injection of 740 MBq $^{99m}Tc$-MDP to evaluate the status of vascularization. The study was performed from the 3 to 33 weeks after surgery. According to the visual analysis, activity greater than nasal bridge was graded as 4, equal to the nasal bridge as 3, less than nasal bridge but greater than normal orbit as 2, greater than normal orbit but less than grade 2 as 1. Uptake ratio was also calculated by measuring the implants activity (H) and contralateral orbit activity (N). Grading score and uptake ratio were compared with clinical outcome of vascularization. Additionally, we also analyzed the vascularization status as time lapse between primary surgery and scintigraphic study and surgical methods. Results: Twenty-one patients who had bone scintigraphy at 11 weeks after surgery showed increased uptake above grade 2 and greater H/N ratio than 1.16. Of these, 19 patients who had drilling surgery for permanent peg application showed adequate bleeding during the procedure. The activity grade and uptake ratio were inversely correlated with vascular ingrowth. Higher than grade 2 or greater than 1.56 in H/N ratio seemed to be an indicator for better prognosis. Accomplishment of vascularization was not affected by the surgical way such as enucleation or evisceration. Conclusion: $^{99m}Tc$-MDP bone scintigraphy can be a useful method to evaluate the vascularized status of implants. Adequate time for $^{99m}Tc$-MDP bone scintigraphy may be 11-20 weeks after enucleation or evisceration.

  • PDF

Evaluation of Vascularization of Hydroxyapatite Ocular Implants by $^{99m}Tc-MDP$ Bone Scan : Preliminary Study ($^{99m}Tc-MDP$ 골주사를 이용한 Hydroxyapatite 안구보충물의 혈관신생에 관한 예비연구)

  • Kim, Jong-Deok;Shin, Sung-Gyun;Lee, Sung-Woo
    • The Korean Journal of Nuclear Medicine
    • /
    • v.29 no.4
    • /
    • pp.518-525
    • /
    • 1995
  • 목적 : 안구제거술 후에 삽입한 hydroxyapatite 안구보충물내로 혈관신생이 완전하게 일어 나는 시기를 알아보기 위함이다. 방법 : 안구제거술을 받은 43예의 환자(남자 33예, 여자 10예, 14-56세)에게 대부분 변경되지 않은 방법으로 hydroxyapatite 안구보충물을 삽입한 후 10-23주 사이에 다양한 간격(10-12 주 2예, 13-16주 18예, 17-20주 20예, 21-23주 3예)을 두고 $^{99m}Tc-MDP$ 골주사를 시행하여 보충물내로의 혈관신생 정도를 전향적으로 측정하였다. 정면 및 측면촬영의 정적영상에서 안구보충물의 방사능섭취가 비교(nasal bridge)의 방사능섭취보다 약할 경우를 grade 1, 같을 경을 grade 2, 강할 경우를 grade 3로 나누었으며 grade 2와 3을 혈관신생이 완전하다고 정의하였다. 또한 43예 모두에서 방사능섭취 정도와 관계없이 안구보충물 삽입후 평균 21주되는 시기에 안구보충물에 구멍을 내어 이 구멍으로부터의 출혈여부를 확인한 후 운동성나사(motility peg)를 끼워 의안(prosthesis)과 연결하였다. 43예중 7예에서는 $^{99m}Tc-MDP$ 골주사와 조영제주입후의 자기공명영상(Gd-DTPA T1-weighted images)을 같은 날짜에 시행하여 각각의 예에서 방사능섭취 정도와 조영제증강 정도를 비교하였다. 결과 : 안구보충물내로 완전하게 혈관신생이 일어났던 grade 2와 3의 비율은 안구보충물삽입후 10-12주에서는 0%, 13-16주 33%, 17-20주 50%, 21-23주 67%로써 시간경과에 따라 점차 증가하였다. 골주사소견에 관계없이 안구보충물 삽입후 평균 21주되는 시기에 보충물 앞쪽에 구멍을 내었을 때 43예 모두에서 완전한 혈관신생을 의미하는 출혈을 볼 수 있었다. $^{99m}Tc-MDP$ 골주사와 조영제주입후의 자기공명영상을 둘 다 시행한 7예 각각에서 방사능섭취의 정도와 조영제증강의 정도가 거의 일치하였다. 결론 : 본 예비연구의 결과로써 hydroryapatite 안구보충물 삽입후 21주째에 $^{99m}Tc-MDP$ 골주사를 시행하는 것이 좋을 것으로 생각되며, hydroxyapatite 안구보충물내로의 완전한 혈관신생 여부를 보는 데에는 $^{99m}Tc-MDP$ 골주사가 조영제주입후의 자기공명영상보다 더 경제적이라고 할 수 있겠다.

  • PDF

Biodegradable implants for orbital wall fracture reconstruction

  • Jang, Hyeon Uk;Kim, So Young
    • Archives of Craniofacial Surgery
    • /
    • v.21 no.2
    • /
    • pp.99-105
    • /
    • 2020
  • Background: Due to the different handling properties of unsintered hydroxyapatite particles/poly-L-lactic acid (uHA/PLLA) and polycaprolactone (PCL), we compared the surgical outcomes and the postoperative implantation accuracy between uHA/PLLA and PCL meshes in orbital fracture repair. Methods: Patients undergoing orbital wall reconstruction with PCL and uHA/PLLA mesh, between 2017 and 2019, were investigated retrospectively. The anatomical accuracy of the implant in bony defect replacement and the functional outcomes such as diplopia, ocular motility, and enophthalmos were evaluated. Results: No restriction of eye movement was reported in any patient (n= 30 for each group), 6 months postoperatively. In the PCL group, no patient showed diplopia or enophthalmos, while the uHA/PLLA group showed two patients with diplopia and one with enophthalmos. Excellent anatomical accuracy of implants was observed in 27 and 22 patients of the PCL and uHA/PLLA groups, respectively. However, this study showed that there were neither any significant differences in the surgical outcomes like diplopia and enophthalmos nor any complications with the two well-known implants. Conclusion: PCL implants and uHA/PLLA implants are safe and have similar levels of complications and surgical outcomes in orbital wall reconstruction.